BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33783838)

  • 1. Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches.
    Silkenstedt E; Linton K; Dreyling M
    Br J Haematol; 2021 Oct; 195(2):162-173. PubMed ID: 33783838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantle cell lymphoma-Advances in molecular biology, prognostication and treatment approaches.
    Silkenstedt E; Dreyling M
    Hematol Oncol; 2021 Jun; 39 Suppl 1():31-38. PubMed ID: 34105823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle cell lymphoma-Update on molecular biology, prognostication and treatment approaches.
    Silkenstedt E; Dreyling M
    Hematol Oncol; 2023 Jun; 41 Suppl 1():36-42. PubMed ID: 37294961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
    Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
    Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Risk Mantle Cell Lymphoma in the Era of Novel Agents.
    Nabrinsky E; Danilov AV; Koller PB
    Curr Hematol Malig Rep; 2021 Feb; 16(1):8-18. PubMed ID: 33507515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma.
    Klener P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in genomics and therapeutics in mantle cell lymphoma.
    Lu T; Zhang J; McCracken JM; Young KH
    Cancer Treat Rev; 2024 Jan; 122():102651. PubMed ID: 37976759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mantle cell lymphoma: biological insights and treatment advances.
    Leonard JP; Williams ME; Goy A; Grant S; Pfreundschuh M; Rosen ST; Sweetenham JW
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):267-77. PubMed ID: 19717376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.
    Jain P; Wang M
    Am J Hematol; 2019 Jun; 94(6):710-725. PubMed ID: 30963600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Patients With Mantle Cell Lymphoma Do Not Need Aggressive Therapy.
    Ruan J; Martin P
    Curr Hematol Malig Rep; 2016 Jun; 11(3):234-40. PubMed ID: 27068437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
    Nastoupil LJ; Koff JL; Flowers CR
    Oncology (Williston Park); 2013 Oct; 27 Suppl 2():8-12. PubMed ID: 25374999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
    Beà S; Amador V
    Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.
    Williams ME; Connors JM; Dreyling MH; Gascoyne RD; Kahl BS; Leonard JP; Press OW; Wilson WH
    Leuk Lymphoma; 2011 Jan; 52(1):24-33. PubMed ID: 21133727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized approaches for treatment-naïve mantle cell lymphoma.
    Qualls D; Kumar A
    Expert Rev Hematol; 2023 Feb; 16(2):95-107. PubMed ID: 36748785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
    Jing C; Zheng Y; Feng Y; Cao X; Xu C
    Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent clonal evolution of a common precursor to mantle cell lymphoma and classic Hodgkin lymphoma.
    Tashkandi H; Petrova-Drus K; Batlevi CL; Arcila ME; Roshal M; Sen F; Yao J; Baik J; Bilger A; Singh J; de Frank S; Kumar A; Aryeequaye R; Zhang Y; Dogan A; Xiao W
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31395597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathogenesis of Mantle Cell Lymphoma.
    Navarro A; Beà S; Jares P; Campo E
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.